ACADIA Pharmaceuticals, Inc. (ACAD)
29.60
+0.02
(+0.07%)
USD |
NASDAQ |
Aug 27, 11:24
ACADIA Pharmaceuticals EPS Diluted (TTM) : 2.220 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.220 |
| March 31, 2026 | 2.196 |
| December 31, 2025 | 2.288 |
| September 30, 2025 | 1.554 |
| June 30, 2025 | 1.331 |
| March 31, 2025 | 1.374 |
| December 31, 2024 | 1.360 |
| September 30, 2024 | 0.7725 |
| June 30, 2024 | 0.1785 |
| March 31, 2024 | -0.0156 |
| December 31, 2023 | -0.3801 |
| September 30, 2023 | -0.9127 |
| June 30, 2023 | -0.6838 |
| March 31, 2023 | -0.901 |
| December 31, 2022 | -1.337 |
| September 30, 2022 | -1.347 |
| June 30, 2022 | -1.270 |
| March 31, 2022 | -1.333 |
| December 31, 2021 | -1.047 |
| September 30, 2021 | -1.198 |
| June 30, 2021 | -1.643 |
| March 31, 2021 | -1.639 |
| December 31, 2020 | -1.790 |
| September 30, 2020 | -1.714 |
| June 30, 2020 | -1.467 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.578 |
| December 31, 2019 | -1.604 |
| September 30, 2019 | -1.758 |
| June 30, 2019 | -1.968 |
| March 31, 2019 | -2.097 |
| December 31, 2018 | -1.945 |
| September 30, 2018 | -1.997 |
| June 30, 2018 | -2.03 |
| March 31, 2018 | -2.07 |
| December 31, 2017 | -2.35 |
| September 30, 2017 | -2.45 |
| June 30, 2017 | -2.53 |
| March 31, 2017 | -2.61 |
| December 31, 2016 | -2.34 |
| September 30, 2016 | -2.14 |
| June 30, 2016 | -1.92 |
| March 31, 2016 | -1.68 |
| December 31, 2015 | -1.63 |
| September 30, 2015 | -1.46 |
| June 30, 2015 | -1.32 |
| March 31, 2015 | -1.15 |
| December 31, 2014 | -0.94 |
| September 30, 2014 | -0.79 |
| June 30, 2014 | -0.66 |
| March 31, 2014 | -0.55 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Incyte Corp. | 7.846 |
| Agios Pharmaceuticals, Inc. | -7.010 |
| Biogen, Inc. | 5.647 |
| Insmed, Inc. | -4.105 |
| Vertex Pharmaceuticals, Inc. | 17.19 |